THE United States has handed over $1 billion to British drugmaker AstraZeneca Plc to help develop a coronavirus vaccine which could be ready by September.
The pharmaceutical company received the money from the US Biomedical Advanced Research and Development Authority to develop the vaccine at the University of Oxford. AstraZenaca said it had secured capacity to make one billion doses of the COVID-19 vaccine, with the first agreement relating to the supply of 400 million doses. But while human trials are currently underway, success is not guaranteed.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'It so exciting to wake up to good news': Vaccine trial volunteer on potential coronavirus breakthroughWhen Jennifer Haller started trial number of global deaths stood at just 9,000 she tells Andrew Buncombe
Read more »
Coronavirus: 'Campus experience' on hold as Cambridge moves lectures online for next academic yearA recent report suggested UK universities could lose more than £2bn because of coronavirus.
Read more »
Singapore sentences man to death via Zoom callMalaysian man receives sentence remotely for role in 2011 drug deal as city-state tries to curb its coronavirus rates
Read more »
'An individual decision': Trump defends taking unproved coronavirus drug hydroxychloroquine – videoThe US president has defended his use of the anti-malaria drug and dismissed a study indicating it was not an effective coronavirus treatment
Read more »
Coronavirus US live: Trump claims to take hydroxychloroquine and threatens to withdraw US from WHOPresident claimed to be taking anti-malarial drug despite FDA warnings, as coronavirus cases in the US pass 1.5 million and number of deaths pass 90,000
Read more »
Why are more BAME people dying from coronavirus?Coronavirus is affecting BAME communities disproportionately, so it's important to understand how to stay safe BBCAsianNetwork has the latest advice, support and guidance for everyone
Read more »